Aura Biosciences Inc (AURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,251 | -23,617 | -14,779 | -5,927 | -22,206 |
| Depreciation Amortization | 831 | 601 | 385 | 185 | 831 |
| Accounts payable and accrued liabilities | 1,054 | 891 | 1,612 | 700 | N/A |
| Other Working Capital | -315 | 1,682 | 2,254 | 428 | -3,679 |
| Other Operating Activity | 1,271 | 119 | -1,106 | -523 | 733 |
| Operating Cash Flow | $-32,410 | $-20,324 | $-11,634 | $-5,137 | $-24,321 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,125 | -1,306 | -733 | -71 | -771 |
| Investing Cash Flow | $-2,125 | $-1,306 | $-733 | $-71 | $-771 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 79,046 | 305 | 285 | 265 | N/A |
| Other Financing Activity | 87,213 | 85,812 | 86,948 | 87,224 | 10,036 |
| Financing Cash Flow | $166,259 | $86,117 | $87,233 | $87,489 | $10,036 |
| Beginning Cash Position | 17,487 | 17,487 | 17,487 | 17,487 | 32,543 |
| End Cash Position | 149,211 | 81,974 | 92,353 | 99,768 | 17,487 |
| Net Cash Flow | $131,724 | $64,487 | $74,866 | $82,281 | $-15,056 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,410 | -20,324 | -11,634 | -5,137 | -24,321 |
| Capital Expenditure | -2,125 | -1,306 | -733 | -71 | N/A |
| Free Cash Flow | -34,535 | -21,630 | -12,367 | -5,208 | -24,321 |